One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 690,000 shares of Takeda Pharmaceutical Co. Ltd. (NYSE: TAK | TAK Price Prediction) on Tuesday, as the share price of this fund traded was up 2% in the day’s session. Its share price has greatly improved over the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 692,660 shares of Takeda. At Tuesday’s closing price, this would have valued this sale at roughly $9.8 million. This is only a small fraction of the total holdings. This fund is flat over the past 52 weeks.
[nativounit]
Here is a quick look at all the other sales that took place across all ARK ETFs:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | OPEN | OPENDOOR TECHNOLOGIES | 166,353 |
| ARKF | Z | ZILLOW | 123,790 |
| ARKG | INCY | INCYTE | 6,219 |
| ARKG | TAK | TAKEDA PHARMACEUTICAL | 692,660 |
| ARKG | VEEV | VEEVA SYSTEMS | 31,755 |
| ARKQ | LMT | LOCKHEED MARTIN | 4,885 |
| ARKQ | U | UNITY SOFTWARE | 11,000 |
| ARKW | U | UNITY SOFTWARE | 112,381 |
| ARKX | HOFP | THALES | 15,040 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
[recirclink id=994210][wallst_email_signup]